(Q44230702)

1 December 2017

title

Oxidative stress and disturbed glutamate transport in spinal muscular atrophy (English)

1 reference

1 December 2017

main subject

spinal muscular atrophy

1 reference

Masaharu Hayashi

1

1 reference

1 December 2017

Satoshi Araki

2

1 reference

1 December 2017

Nobutaka Arai

3

1 reference

1 December 2017

Satoko Kumada

4

1 reference

1 December 2017

Masahiro Itoh

5

1 reference

1 December 2017

Kimiko Tamagawa

6

1 reference

1 December 2017

Masaya Oda

7

1 reference

1 December 2017

Yoshio Morimatsu

8

1 reference

1 December 2017

publication date

1 December 2002

1 reference

1 December 2017

published in

Brain and Development

1 reference

1 December 2017

volume

24

1 reference

1 December 2017

issue

8

1 reference

1 December 2017

page(s)

770-775

1 reference

Identification and characterization of a spinal muscular atrophy-determining gene

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2802%2900103-1

7 January 2021

The gene for neuronal apoptosis inhibitory protein is partially deleted in individuals with spinal muscular atrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2802%2900103-1

7 January 2021

Molecular diagnosis of spinal muscular atrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2802%2900103-1

7 January 2021

A study of cell death in Werdnig Hoffmann disease brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2802%2900103-1

7 January 2021

Ultrastructural analysis and TUNEL demonstrate motor neuron apoptosis in Werdnig-Hoffmann disease

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2802%2900103-1

7 January 2021

Increased 3-nitrotyrosine in both sporadic and familial amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2802%2900103-1

7 January 2021

Selective loss of glial glutamate transporter GLT‐1 in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2802%2900103-1

7 January 2021

Immunohistochemical study of advanced glycation end products in aging and Alzheimer's disease brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2802%2900103-1

7 January 2021

Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2802%2900103-1

7 January 2021

Oxidative stress and disturbed glutamate transport in hereditary nucleotide repair disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2802%2900103-1

7 January 2021

Reactive oxygen species-induced molecular damage and its application in pathology.

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2802%2900103-1

7 January 2021

Oxidative damage is the earliest event in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2802%2900103-1

7 January 2021

Localization of neuronal and glial glutamate transporters

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2802%2900103-1

7 January 2021

Distribution of glutamate transporter subtypes during human brain development

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2802%2900103-1

7 January 2021

Glutamate transporter alterations in Alzheimer disease are possibly associated with abnormal APP expression.

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2802%2900103-1

7 January 2021

10.1016/S0387-7604(02)00103-1

Identifiers

DOI

1 reference

1 December 2017

1 reference